Chen Bingjie, Wu Xianrui, Ruan Yongsen, Zhang Yulin, Cai Qichun, Zapata Luis, Wu Chung-I, Lan Ping, Wen Haijun
State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou510275, China.
GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Natl Sci Rev. 2022 Nov 11;9(12):nwac250. doi: 10.1093/nsr/nwac250. eCollection 2022 Dec.
Despite the concern of within-tumor genetic diversity, this diversity is in fact limited by the kinship among cells in the tumor. Indeed, genomic studies have amply supported the 'Nowell dogma' whereby cells of the same tumor descend from a single progenitor cell. In parallel, genomic data also suggest that the diversity could be >10-fold larger if tumor cells are of multiple origins. We develop an evolutionary hypothesis that a single tumor may often harbor multiple cell clones of independent origins, but only one would be large enough to be detected. To test the hypothesis, we search for independent tumors within a larger one (or tumors-in-tumor). Very high density sampling was done on two cases of colon tumors. Case 1 indeed has 13 independent clones of disparate sizes, many having heavy mutation burdens and potentially highly tumorigenic. In Case 2, despite a very intensive search, only two small independent clones could be found. The two cases show very similar movements and metastasis of the dominant clone. Cells initially move actively in the expanding tumor but become nearly immobile in late stages. In conclusion, tumors-in-tumor are plausible but could be very demanding to find. Despite their small sizes, they can enhance the within-tumor diversity by orders of magnitude. Such increases may contribute to the missing genetic diversity associated with the resistance to cancer therapy.
尽管人们关注肿瘤内部的基因多样性,但实际上这种多样性受到肿瘤细胞间亲缘关系的限制。的确,基因组研究充分支持了“诺韦尔法则”,即同一肿瘤的细胞源自单个祖细胞。与此同时,基因组数据还表明,如果肿瘤细胞有多个起源,那么多样性可能会大10倍以上。我们提出了一种进化假说,即单个肿瘤可能常常包含多个独立起源的细胞克隆,但只有一个克隆大到足以被检测到。为了验证这一假说,我们在一个较大的肿瘤内部(或肿瘤内的肿瘤)寻找独立的肿瘤。对两例结肠肿瘤进行了非常高密度的采样。病例1确实有13个大小各异的独立克隆,其中许多具有沉重的突变负担且可能具有高度致瘤性。在病例2中,尽管进行了非常深入的搜索,却只发现了两个小的独立克隆。这两个病例显示出优势克隆非常相似的移动和转移情况。细胞最初在不断扩大的肿瘤中活跃移动,但在后期几乎不再移动。总之,肿瘤内的肿瘤是有可能存在的,但可能很难找到。尽管它们体积小,但它们可以将肿瘤内部的多样性提高几个数量级。这种增加可能导致与癌症治疗耐药性相关的基因多样性缺失。